drugset / Trial / NCT07094763
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
Recruiting
406 enrolled
The First Affiliated Hospital of University of Science and Technology of China
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aims to evaluate the efficacy and safety of tenecteplase (TNK) intravenous thrombolysis within the extended time window (4.5 to 24 hours) in patients with acute posterior circulation ischemic stroke.
Timeline
- Start
- 2025-11-05
- Primary completion
- 2027-10-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenecteplase | Protein / enzyme biologic | 0.25 mg/kg | Intravenous |